These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 20669963)

  • 1. Estradiol binding prevents ApoB-100 misfolding in electronegative LDL(-).
    Brunelli R; Balogh G; Costa G; De Spirito M; Greco G; Mei G; Nicolai E; Vigh L; Ursini F; Parasassi T
    Biochemistry; 2010 Aug; 49(34):7297-302. PubMed ID: 20669963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misfolding of apoprotein B-100, LDL aggregation and 17-β -estradiol in atherogenesis.
    Brunelli R; De Spirito M; Mei G; Papi M; Perrone G; Stefanutti C; Parasassi T
    Curr Med Chem; 2014; 21(20):2276-83. PubMed ID: 24438526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low density lipoprotein misfolding and amyloidogenesis.
    Parasassi T; De Spirito M; Mei G; Brunelli R; Greco G; Lenzi L; Maulucci G; Nicolai E; Papi M; Arcovito G; Tosatto SC; Ursini F
    FASEB J; 2008 Jul; 22(7):2350-6. PubMed ID: 18292214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation in human plasma of misfolded, aggregation-prone electronegative low density lipoprotein.
    Greco G; Balogh G; Brunelli R; Costa G; De Spirito M; Lenzi L; Mei G; Ursini F; Parasassi T
    Biophys J; 2009 Jul; 97(2):628-35. PubMed ID: 19619478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One site on the apoB-100 specifically binds 17-beta-estradiol and regulates the overall structure of LDL.
    Brunelli R; Greco G; Barteri M; Krasnowska EK; Mei G; Natella F; Pala A; Rotella S; Ursini F; Zichella L; Parasassi T
    FASEB J; 2003 Nov; 17(14):2127-9. PubMed ID: 14500554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electronegative low-density lipoprotein. A link between apolipoprotein B misfolding, lipoprotein aggregation and proteoglycan binding.
    Sánchez-Quesada JL; Villegas S; Ordóñez-Llanos J
    Curr Opin Lipidol; 2012 Oct; 23(5):479-86. PubMed ID: 22964994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of chylomicron phospholipids and apoproteins in the rat.
    Tall AR; Green PH; Glickman RM; Riley JW
    J Clin Invest; 1979 Oct; 64(4):977-89. PubMed ID: 225354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoproteins of the newborn rat. Reciprocal development of low density lipoproteins and apoprotein E-rich high density lipoproteins.
    Perrin Ansart MC; Vacher D; Girard-Globa A
    J Dev Physiol; 1988 Aug; 10(4):321-34. PubMed ID: 3204263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial oxidative stress.
    Ursini F; Sevanian A
    Biol Chem; 2002; 383(3-4):599-605. PubMed ID: 12033449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel lecithin-cholesterol acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation.
    Vohl MC; Neville TA; Kumarathasan R; Braschi S; Sparks DL
    Biochemistry; 1999 May; 38(19):5976-81. PubMed ID: 10320323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In.
    Pepe MG; Curtiss LK
    J Immunol; 1986 May; 136(10):3716-23. PubMed ID: 3701060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipids, lipoproteins and apolipoproteins in normal newborns].
    Casanueva V; Cid X; Chiang MT; Molina M; Ferrada MC; Pérez R; Casanueva P
    Rev Med Chil; 1998 Sep; 126(9):1073-8. PubMed ID: 9922510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral contraceptives on circulating lipids and lipoproteins: maximizing benefit, minimizing risk.
    LaRosa JC
    Int J Fertil; 1989; 34 Suppl():71-84. PubMed ID: 2576264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans.
    Bancells C; Benítez S; Ordóñez-Llanos J; Öörni K; Kovanen PT; Milne RW; Sánchez-Quesada JL
    J Biol Chem; 2011 Jan; 286(2):1125-33. PubMed ID: 21078674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
    Sharma R; Singh B; Mahajan M
    Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein.
    Asatryan L; Hamilton RT; Isas JM; Hwang J; Kayed R; Sevanian A
    J Lipid Res; 2005 Jan; 46(1):115-22. PubMed ID: 15489541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.